CLIA Certificates of Waiver for Drug Testing in Behavioral Health: What Operators Need on File

Most behavioral health programs that read urine drug cups do not think of themselves as running a laboratory. Under federal law, they are. The Clinical Laboratory Improvement Amendments (CLIA) apply to any site that tests human specimens to inform diagnosis, treatment or assessment, and a presumptive drug screen used to adjust a treatment plan, change a level of care or document progress falls squarely inside that definition. The good news is that most point-of-care drug screening qualifies as waived testing, which carries the lightest set of CLIA obligations. The bad news is that “light” is not “none,” and the gaps we find on mock surveys tend to be the same handful every time.

This post walks through what a CLIA Certificate of Waiver actually covers, where programs fall out of compliance without noticing, and what to put on file so a surveyor, a payer auditor or a state licensing reviewer can confirm it in minutes. It is operational guidance, not legal advice, and the primary source for every requirement below is the CMS CLIA program.

What a CLIA Certificate of Waiver Covers

A CLIA Certificate of Waiver is valid for two years, is issued to a specific testing site, and covers only tests the FDA has categorized as waived, performed exactly as the manufacturer’s instructions direct. A behavioral health program that reads urine drug cups or dip cards to make treatment decisions is performing laboratory testing under CLIA and needs the certificate in place before the first specimen is tested, not after an auditor asks for it.

Three limits in that paragraph do most of the work. The certificate is site-bound: it lists an address, and a program that opens a second location or moves its outpatient office generally needs to update or add a certificate rather than assume the original one travels. The certificate is test-bound: it covers waived tests, and waiver status attaches to a specific test system and specimen type, not to “drug cups” as a category. And it is procedure-bound: a waived test performed outside the manufacturer’s instructions, such as reading a cup after the specified read window or skipping a required control, is no longer being performed as a waived test.

You apply through your state survey agency using the CMS-116 application, pay the certificate fee CMS bills you, and receive a CLIA number. That number belongs on your claims, on your certificate posting and in your compliance file.

Why Waived-Testing Findings Happen

Waived sites are not routinely inspected the way moderate- and high-complexity labs are, which is exactly why problems accumulate quietly. When a CLIA finding does surface, it is usually through a Joint Commission or CARF survey, a payer records request, a state licensing visit or a complaint. The causes we see repeat across programs:

• Supply substitution: purchasing switches to a cheaper cup or a new version of the same brand, and nobody confirms the new product is on the FDA waived list for urine.
• Stale certificate data: the certificate still lists a former address, a former name or a laboratory director who left the organization a year ago.
• Silent expiration: the two-year renewal lands in the same month as a CARF resurvey or a licensure renewal and slips, leaving a window in which every screen was performed without a valid certificate.
• Read-window drift: staff read cups when they get back to them rather than inside the timed window the package insert specifies.
• Undocumented competency: the nurses and techs reading cups were trained once at orientation, and no one can produce evidence of it.
• Expired lots on the shelf: a box past its expiration date is still in the supply closet, and the result log does not record lot numbers, so there is no way to prove an expired kit was never used.

What a Surveyor Actually Asks For

On accreditation surveys that include waived testing, the reviewer typically starts at the point of care, not in the compliance office. They will ask a staff member to walk through how a specimen is collected, how the cup is read and how the result gets into the record. Then they will ask for the paperwork behind it. Expect requests for:

• The current CLIA certificate, with an address that matches the building they are standing in.
• The package insert for the exact product in use, and evidence that your written procedure matches it.
• A list of staff authorized to perform the test, with training and competency documentation for each.
• Quality control records, if the manufacturer’s instructions call for controls.
• A sample of client records showing results, the date and time, who performed the test and how the result informed care.

The Joint Commission addresses waived testing in its own standards, and CARF reviewers will look at the same practices through the lens of your written procedures and staff qualifications. Check your current manual for the exact requirements rather than relying on a summary, including this one.

The Waived-Test File: What to Keep and Where

We recommend one file, physical or electronic, owned by a named person, that answers every question above without a search. In practice it contains:

• Certificate and identifiers: the CLIA certificate, the CLIA number, the expiration date and a calendar entry for the renewal set at least 90 days ahead.
• Test menu: every waived test performed at the site, each with its product name, manufacturer, specimen type and a dated screenshot of its listing in the FDA CLIA test categorization database.
• Procedures: a written procedure for each test that mirrors the current package insert, with the insert attached and the version date noted.
• People: a roster of authorized testers, initial training records and periodic competency checks.
• Logs: a result log or EHR report that captures date, time, tester, lot number and expiration date, plus any quality control results.

The lot-number column is the one most programs skip and the one that saves them. If a payer or surveyor asks whether a result came from an expired kit, a log with lot numbers answers the question. A log without them leaves you arguing from memory.

Billing: Where CLIA and Claims Meet

CLIA status also shows up on the revenue side. Medicare and many commercial payers expect the CLIA number on claims for laboratory services, and waived tests billed to Medicare are reported with the QW modifier. A claim for a presumptive drug screen from a site with a lapsed certificate, or for a test that is not on the waived list, is a claim for a service the site was not certified to perform. That exposure is retroactive: an expired certificate discovered in a records request can put every screen billed during the gap into question.

Payer policies on presumptive drug testing vary in frequency limits, medical necessity documentation and the codes they accept. Treat your payer contracts and the applicable CMS guidance as the controlling source and align your testing policy to the strictest one you bill.

Five Things to Check Before the End of the Day

This is a 30-minute exercise for a clinical director or compliance lead, and it closes most of the exposure described above:

1. Pull your CLIA certificate. Confirm the address, the facility name and the laboratory director match today’s reality, and write the expiration date on your compliance calendar.
2. Walk to the supply closet. Take the box of cups actually in use, find its exact product name and look it up in the FDA CLIA database. Confirm it is categorized as waived for the specimen type you collect.
3. Check every box on the shelf for its expiration date and remove anything expired.
4. Pick three recent client screens in the EHR and confirm each shows date, time, tester and, ideally, lot number.
5. Ask the person who reads cups on the evening shift to describe the read window. Compare the answer to the package insert.

If any of the five turns up a gap, you have found it before a surveyor did. If you would like a second set of eyes, call us at (888) 458-6619.

Where This Fits in Your Broader Compliance Program

Waived testing rarely gets its own owner, which is the root cause behind nearly every finding listed above. It sits between nursing, purchasing and compliance, and each assumes one of the others is watching. Assigning it to a single named person, with the file and calendar described here, is the fix that holds. The SAMHSA clinical guidance on drug testing in treatment settings is also worth reviewing alongside your procedures, since it addresses how results should inform care rather than how the test is run.

Circa Behavioral builds and maintains this kind of operational file as part of our behavioral health compliance services, and our fractional compliance officer engagements include ownership of calendars like CLIA renewal. Programs preparing for an accreditation survey can also fold waived-testing readiness into our Joint Commission accreditation consulting. To talk through your current setup, reach our team at (888) 458-6619.